/term/cash-receipts-from-securities-related-activities/XKRX:203400 ABION (XKRX:203400) Cash Receipts from Securities Related A
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Cash Receipts from Securities Related Activities

ABION (XKRX:203400) Cash Receipts from Securities Related Activities


View and export this data going back to 2014. Start your Free Trial

What is ABION Cash Receipts from Securities Related Activities?

Cash Receipts from Securities Related Activities only applicable to companies reporting Cash Flow from Operations in direct method.

ABION (XKRX:203400) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Cash Receipts from Securities Related Activities
Comparable Companies
XKRX:166480 XKRX:234690 XKRX:348080 XKRX:353810 XKRX:365270 XKRX:389030 XKRX:067370 XKRX:251120 XKRX:065660 XKRX:261780 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
9th FI, HanWha Biz Metro Building, 242 Digital-ro, Guro-gu, Seoul, KOR, 08394
Website
http://www.abionbio.com
ABION Inc is a biopharmaceutical company. It is primarily involved in the research and development new bio pharmaceutical drugs and companion diagnostics systems for the treatment of incurable diseases.